{"id":210831,"title":"Archive 18: Summary of National Advisory Committee on Immunization (NACI) statement: Recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T12:17:06.714000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines/mrna-adolescents/summary.html","snippet":"Archive 18: Summary of National Advisory Committee on Immunization (NACI) statement: Recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age - Canada.ca Skip to main content Skip to \"About government\" We have archived this page and will not be…","rawSnapshotUrl":"/api/snapshots/raw/210831","browseUrl":"https://replay.healtharchive.ca/job-1/20250418121706/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines/mrna-adolescents/summary.html#ha_snapshot=210831","mimeType":"text/html","statusCode":200}